Table 1.

The affinity of ALK-derived peptides for HLA-A*0201 molecules and immunogenicity in HHD mice

Peptide*FIDC50(h)R/T HHD mice1-153% lysis1-155
p280-89 5.6  ±  0.92 3/6 63—49—18 
p282-90 5.4  ±  1.78 4-6 3/6 80—56—50 
p376-85 2.8  ±  0.17 3/6 24—15—15 
p377-85 3  ±  0.35 4-6 3/6 48—24—21 
p621-29 3.5  ±  0.16 4-6 2/6 63—53  
p281-89 3.5  ±  0.65 2/6 42—34  
p456-65 4.2  ±  0.25 2-4 2/6 67—15  
p609-17 2.3  ±  0.35 0/6 < 15  
p615-24 3.3  ±  0.14 0/6 < 15 
Peptide*FIDC50(h)R/T HHD mice1-153% lysis1-155
p280-89 5.6  ±  0.92 3/6 63—49—18 
p282-90 5.4  ±  1.78 4-6 3/6 80—56—50 
p376-85 2.8  ±  0.17 3/6 24—15—15 
p377-85 3  ±  0.35 4-6 3/6 48—24—21 
p621-29 3.5  ±  0.16 4-6 2/6 63—53  
p281-89 3.5  ±  0.65 2/6 42—34  
p456-65 4.2  ±  0.25 2-4 2/6 67—15  
p609-17 2.3  ±  0.35 0/6 < 15  
p615-24 3.3  ±  0.14 0/6 < 15 
*

Position is referred to NPM/ALK sequence.

Ratio (median channel of fluorescence) between the sample and a control containing an irrelevant peptide. Results are expressed as the mean value of 4 experiments ± SEM.

DC50: Half-life of disassociation of HLA-A*02.01/peptide complexes.

F1-153

R/T is responder versus tested mice. Mice were considered as responders when the specific lysis of peptide-loaded RMA-S/HDD target cells was at least 15% above the lysis of RMA-S/HDD.

F1-155

Percent lysis of peptide-loaded RMA-S/HDD cells at an E/T ratio of 60:1. Values correspond to the maximal lysis observed for each responder mouse.

Close Modal

or Create an Account

Close Modal
Close Modal